Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
KTTA

Pasithea Therapeutics (KTTA) stock: insider trades, news & valuation

Strong buying
Close · Oct 9, 2026 $0.47 +6.1% on the day -40.8% over 12 months 52-week range $0.29 – $1.47

Share price and insider trades

KTTA closeInsider buyInsider sale
0.000.501.001.50NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $53,000 on 2026-06-17 · Coastlands Capital LpBought $149,999 on 2025-11-28 · Lawrence Steinman, Simon Dumesnil, Tiago Marques
Bought, 12 months$203K
Sold, 12 months$0
Insiders buying4
Insiders selling0

Pasithea Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $203K and 0 sold $0 of KTTA stock on the open market, including a cluster buy that began Nov 28, 2025.

KTTA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $150K bought (3 trades)$150KQ4 2025Q1 2026Q2 2026: $53K bought (1 trades)$53KQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$53K1—0
Q1 2026—0—0
Q4 2025$150K3—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.4×Last 5 sessions
Insiders' paper profit−$63KOn all tracked purchases -30.8%

Summary

Over the past 12 months, 4 Pasithea Therapeutics Corp. insiders reported open-market purchases totaling $203K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Nov 28, 2025, when 3 insiders bought a combined $150K. Among insiders with enough purchase history to measure, Coastlands Capital Lp (10% Owner) has the highest Insider Score at 77.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jun 22SEC Coastlands Capital Lp10% Owner Buy 100,0003,835,035 held (+3%) $0.53 $53K -11.7% 77
Dec 1SEC Lawrence SteinmanDirector Buy 133,333199,691 held (+201%) $0.75 $100K -37.6% —
Dec 1SEC Simon DumesnilDirector Buy 33,33335,833 held (+1333%) $0.75 $25K -37.6% —
Dec 1SEC Tiago MarquesCEO Buy 33,33373,334 held (+83%) $0.75 $25K -37.6% —

Insiders at Pasithea Therapeutics Corp.

InsiderBoughtSoldLast filingScore
Lawrence SteinmanDirector $100K — Dec 1, 2025 —
Coastlands Capital Lp10% Owner $53K — Jun 22, 2026 77
Simon DumesnilDirector $25K — Dec 1, 2025 —
Tiago MarquesCEO $25K — Dec 1, 2025 —

KTTA stock: common questions

Are Pasithea Therapeutics Corp. insiders buying KTTA stock?

In the past 12 months, 4 insiders reported open-market purchases of KTTA worth $203K. The latest was 10% Owner Coastlands Capital Lp bought $53K of KTTA at $0.53 — first open-market purchase in our records.

Are Pasithea Therapeutics Corp. insiders selling KTTA stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is KTTA's 52-week range?

Over the past year KTTA has traded between $0.29 and $1.47. It last closed at $0.47 on Oct 9, 2026.